Cargando…

Sotrovimab for COVID-19

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542484/
https://www.ncbi.nlm.nih.gov/pubmed/34728886
http://dx.doi.org/10.18773/austprescr.2021.051
_version_ 1784589440434307072
collection PubMed
description
format Online
Article
Text
id pubmed-8542484
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-85424842021-11-01 Sotrovimab for COVID-19 Aust Prescr New Drugs NPS MedicineWise 2021-09-29 2021-10 /pmc/articles/PMC8542484/ /pubmed/34728886 http://dx.doi.org/10.18773/austprescr.2021.051 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Sotrovimab for COVID-19
title Sotrovimab for COVID-19
title_full Sotrovimab for COVID-19
title_fullStr Sotrovimab for COVID-19
title_full_unstemmed Sotrovimab for COVID-19
title_short Sotrovimab for COVID-19
title_sort sotrovimab for covid-19
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542484/
https://www.ncbi.nlm.nih.gov/pubmed/34728886
http://dx.doi.org/10.18773/austprescr.2021.051